These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 28797264

  • 1. Flavonolignans inhibit the arachidonic acid pathway in blood platelets.
    Bijak M, Saluk-Bijak J.
    BMC Complement Altern Med; 2017 Aug 10; 17(1):396. PubMed ID: 28797264
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of the Cytotoxicity and Genotoxicity of Flavonolignans in Different Cellular Models.
    Bijak M, Synowiec E, Sitarek P, Sliwiński T, Saluk-Bijak J.
    Nutrients; 2017 Dec 14; 9(12):. PubMed ID: 29240674
    [Abstract] [Full Text] [Related]

  • 3. Inhibitory Effect of Flavonolignans on the P2Y12 Pathway in Blood Platelets.
    Bijak M, Szelenberger R, Dziedzic A, Saluk-Bijak J.
    Molecules; 2018 Feb 10; 23(2):. PubMed ID: 29439388
    [Abstract] [Full Text] [Related]

  • 4. Flavonolignans Inhibit IL1-β-Induced Cross-Talk between Blood Platelets and Leukocytes.
    Bijak M, Dziedzic A, Synowiec E, Sliwinski T, Saluk-Bijak J.
    Nutrients; 2017 Sep 15; 9(9):. PubMed ID: 28914761
    [Abstract] [Full Text] [Related]

  • 5. Flavonolignans inhibit ADP induced blood platelets activation and aggregation in whole blood.
    Bijak M, Szelenberger R, Saluk J, Nowak P.
    Int J Biol Macromol; 2017 Feb 15; 95():682-688. PubMed ID: 27923566
    [Abstract] [Full Text] [Related]

  • 6. The effect of milk thistle (Silybum marianum) and its main flavonolignans on CYP2C8 enzyme activity in human liver microsomes.
    Albassam AA, Frye RF, Markowitz JS.
    Chem Biol Interact; 2017 Jun 01; 271():24-29. PubMed ID: 28457856
    [Abstract] [Full Text] [Related]

  • 7. Flavonolignans reduce the response of blood platelet to collagen.
    Bijak M, Dziedzic A, Saluk-Bijak J.
    Int J Biol Macromol; 2018 Jan 01; 106():878-884. PubMed ID: 28842200
    [Abstract] [Full Text] [Related]

  • 8. Chemotaxonomic and biosynthetic relationships between flavonolignans produced by Silybum marianum populations.
    AbouZid SF, Ahmed HS, Moawad AS, Owis AI, Chen SN, Nachtergael A, McAlpine JB, Brent Friesen J, Pauli GF.
    Fitoterapia; 2017 Jun 01; 119():175-184. PubMed ID: 28392269
    [Abstract] [Full Text] [Related]

  • 9. The Effect of Silymarin Flavonolignans and Their Sulfated Conjugates on Platelet Aggregation and Blood Vessels Ex Vivo.
    Pourová J, Applová L, Macáková K, Vopršalová M, Migkos T, Bentanachs R, Biedermann D, Petrásková L, Tvrdý V, Hrubša M, Karlíčková J, Křen V, Valentová K, Mladěnka P.
    Nutrients; 2019 Sep 24; 11(10):. PubMed ID: 31554252
    [Abstract] [Full Text] [Related]

  • 10. The study of flavonolignan association patterns in fruits of diverging Silybum marianum (L.) Gaertn. chemotypes provides new insights into the silymarin biosynthetic pathway.
    Martinelli T, Whittaker A, Benedettelli S, Carboni A, Andrzejewska J.
    Phytochemistry; 2017 Dec 24; 144():9-18. PubMed ID: 28863306
    [Abstract] [Full Text] [Related]

  • 11. [Flavonolignans - compounds not only for liver treatment].
    Bijak M.
    Pol Merkur Lekarski; 2017 Jan 23; 42(247):34-37. PubMed ID: 28134230
    [Abstract] [Full Text] [Related]

  • 12. An assessment of pharmacokinetics and antioxidant activity of free silymarin flavonolignans in healthy volunteers: a dose escalation study.
    Zhu HJ, Brinda BJ, Chavin KD, Bernstein HJ, Patrick KS, Markowitz JS.
    Drug Metab Dispos; 2013 Sep 23; 41(9):1679-85. PubMed ID: 23835761
    [Abstract] [Full Text] [Related]

  • 13. Silybin and its congeners: from traditional medicine to molecular effects.
    Křen V, Valentová K.
    Nat Prod Rep; 2022 Jun 22; 39(6):1264-1281. PubMed ID: 35510639
    [Abstract] [Full Text] [Related]

  • 14. Skin Protective Activity of Silymarin and its Flavonolignans.
    Vostálová J, Tinková E, Biedermann D, Kosina P, Ulrichová J, Rajnochová Svobodová A.
    Molecules; 2019 Mar 14; 24(6):. PubMed ID: 30875758
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics and metabolic profile of free, conjugated, and total silymarin flavonolignans in human plasma after oral administration of milk thistle extract.
    Wen Z, Dumas TE, Schrieber SJ, Hawke RL, Fried MW, Smith PC.
    Drug Metab Dispos; 2008 Jan 14; 36(1):65-72. PubMed ID: 17913795
    [Abstract] [Full Text] [Related]

  • 16. Two flavonolignans from milk thistle (Silybum marianum) inhibit CYP2C9-mediated warfarin metabolism at clinically achievable concentrations.
    Brantley SJ, Oberlies NH, Kroll DJ, Paine MF.
    J Pharmacol Exp Ther; 2010 Mar 14; 332(3):1081-7. PubMed ID: 19934397
    [Abstract] [Full Text] [Related]

  • 17. Antiplatelet effect of catechol is related to inhibition of cyclooxygenase, reactive oxygen species, ERK/p38 signaling and thromboxane A2 production.
    Chang MC, Chang HH, Wang TM, Chan CP, Lin BR, Yeung SY, Yeh CY, Cheng RH, Jeng JH.
    PLoS One; 2014 Mar 14; 9(8):e104310. PubMed ID: 25122505
    [Abstract] [Full Text] [Related]

  • 18. Interaction of isolated silymarin flavonolignans with iron and copper.
    Tvrdý V, Catapano MC, Rawlik T, Karlíčková J, Biedermann D, Křen V, Mladěnka P, Valentová K.
    J Inorg Biochem; 2018 Dec 14; 189():115-123. PubMed ID: 30245273
    [Abstract] [Full Text] [Related]

  • 19. Identification of UDP-glucuronosyltransferases involved in the metabolism of silymarin flavonolignans.
    Vrba J, Papoušková B, Lněničková K, Kosina P, Křen V, Ulrichová J.
    J Pharm Biomed Anal; 2020 Jan 30; 178():112972. PubMed ID: 31727359
    [Abstract] [Full Text] [Related]

  • 20. Tyrosinase inhibitory study of flavonolignans from the seeds of Silybum marianum (Milk thistle).
    Kim JY, Kim JY, Jenis J, Li ZP, Ban YJ, Baiseitova A, Park KH.
    Bioorg Med Chem; 2019 Jun 15; 27(12):2499-2507. PubMed ID: 30871862
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.